Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

Last updated: June 14, 2012
Sponsor: Novartis
Overall Status: Completed

Phase

4

Condition

Neck Pain

Chronic Pain

Treatment

N/A

Clinical Study ID

NCT01335724
862-P-201
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to evaluate the efficacy and safety of diclofenac 1.16% gel compared with placebo applied four times a day in subjects with acute neck pain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female subjects, age range 18 and over.

  • Patient with acute neck pain meeting baseline pain intensity level and duration

Exclusion

Exclusion Criteria:

  • Pain medication was taken within the 6 hours that precede randomization.

  • Patient with chronic neck pain as defined as pain for 3 months or longer

  • Any neck pain that is attributable to any organic disease, such as prolapsed disc,spondylolisthesis, osteomalacia, inflammatory arthritis, metabolic, neurologicaldiseases or tumors.

  • Any recent strains of the neck muscles documented by the clinical evaluation andanamnesis

Study Design

Total Participants: 72
Study Start date:
April 01, 2011
Estimated Completion Date:
July 31, 2011

Connect with a study center

  • NCH investigative site

    Cologne,
    Germany

    Site Not Available

  • NCH investigative site

    Essen,
    Germany

    Site Not Available

  • NCH investigative site

    Munich,
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.